Murabe H, Mukoyama M, Tanaka I, Nakao K
Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine.
Nihon Rinsho. 1998 Jul;56(7):1919-24.
Adrenomedullin(AM) is a potent hypotensive peptide originally isolated from human pheochromocytoma. AM exerts various biological actions such as vasodilation, bronchodilation and natriuresis, by stimulating cAMP production and increasing free Ca2+ levels through the specific receptors. Although an orphan receptor cloned from rat lung, which contained seven transmembrane domains, was proved to be one of the AM receptors, it is now considered by many studies that other receptor subtypes should be present. The precise signal transduction mechanism for the AM receptor is not fully elucidated yet, but it is supposed that AM acts against proliferative changes of vascular and mesangial cells as seen in hypertensive states, at least partly by inhibiting the MAP kinase pathway. Further studies on the AM receptor subtypes and their intracellular signaling mechanisms are needed to clarify the role of AM in various pathophysiological conditions.
肾上腺髓质素(AM)是一种强效降压肽,最初从人嗜铬细胞瘤中分离出来。AM通过刺激环磷酸腺苷(cAMP)生成并通过特定受体增加游离钙离子(Ca2+)水平,发挥多种生物学作用,如血管舒张、支气管舒张和利钠作用。尽管从大鼠肺中克隆出的一种含有七个跨膜结构域的孤儿受体被证明是AM受体之一,但现在许多研究认为还应存在其他受体亚型。AM受体的确切信号转导机制尚未完全阐明,但据推测,AM至少部分通过抑制丝裂原活化蛋白激酶(MAP)激酶途径,对抗高血压状态下血管和系膜细胞的增殖变化。需要对AM受体亚型及其细胞内信号传导机制进行进一步研究,以阐明AM在各种病理生理状况中的作用。